Loading...

Moffitt Cancer Center Researcher Explains Benefit of New Gardasil 9 Vaccine

568 views

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 12, 2014

Moffitt's Anna R. Giuliano, Ph.D., explains how Gardasil 9 will further protect women from harmful strains of HPV. The new FDA-approved drug has the potential to prevent 90 percent of cervical, vulvar, vaginal and anal cancers.

Giuliano is the recipient of several large grants from the NIH, the National Cancer Institute, and the Centers for Disease Control and Prevention for research on HPV infection among women and men.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...